Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature review

Journal of Rheumatology

Volumn 26, Issue 4, 1999, Pages 955-960

  Ruof, Jörg ^a   Stucki, Gerold ^a,b  

^a Rheumaklinik und Institut fur Physikalische Medizin   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Ankylosing Spondylitis; Functional Index

Indexed keywords

ANTIRHEUMATIC AGENT;

ANKYLOSING SPONDYLITIS; ARTICLE; DAILY LIFE ACTIVITY; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; OUTCOMES RESEARCH; PHYSIOTHERAPY; PRIORITY JOURNAL; RHEUMATIC DISEASE;

ACTIVITIES OF DAILY LIVING; DATABASES, FACTUAL; DISABILITY EVALUATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 0032964249     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S, on behalf of the Assessment in Ankylosing Spondylitis Working Group. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997;24:2225-9.
2. Hidding A, van Santen M, van der Linden S, et al. Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis, and fibromyalgia. J Rheumatol l994;21:818-23.
3. Bakker C, Boers M, van der Linden S. Measures to assess ankylosing spondylitis: taxonomy, review and recommendations. J Rheumatol 1993;20:1724-30.
4. Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988;15:302-7.
5. Dougados M, Gueguen A, Nakache JP, Nguyen M, Amor B. Evaluation of a functional index for patients with ankylosing spondylitis [letter]. J Rheumatol 1990:17:1254-5.
6. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994:21:2281-5.
7. Boers M, Brooks P, Strand VC, Tugwell P. The OMERACT filter for outcome measures in rheumatology [editorial]. J Rheumatol 1998:25:198-9.
8. Creemers MCW, van't Hof M, Franssen MJAM, van de Putte LBA, Gribnau FWJ, van Riel PLCM. A Dutch version of the functional index for ankylosing spondylitis. Development and validation in a long-term study. Br J Rheumatol 1994:33:824-6.
9. Creemers MCW, van't Hof MA, Franssen MJAM, van de Putte LBA, Gribnau FWJ, van Riel PLCM. Disease activity in ankylosing spondylitis: selection of a core set of variables and a first step in the development of a disease activity score. Br J Rheumatol 1996;35:867-73.
10. Moncur C, Cannon GW, Shaw M, Willardson D, Clegg DO. Inter-observer reliability of the Spondylitis Functional Index Instruments for assessing spondylarthropathies. Arthritis Care Res 1996;9:182-8.
11. Jones SD, Calin A, Steiner A. An update on the Bath ankylosing spondylitis disease activity and functional indices (BASDAI, BASFI): excellent Cronbach's alpha scores [letter]. J Rheumatol 1996;23:407.
12. Daltroy LH, Larson MG, Roberts WN, Liang MH. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990; 17:946-50.
13. Bakker C, Rutten van Mölken M, Hidding A, et al. Patient utilities in ankylosing spondylitis and the association with other outcome measures. J Rheumatol 1994:21:1298-304.
14. Stucki G, Liang MH, Phillips C, Katz JN. The Short-Form-36 is preferable to the SIP as a generic health status measure in patients undergoing elective total hip arthroplasty. Arthritis Care Res 1995:8:174-81.
15. Calin A, Gueguen A, Nakache JP, Zeidler H, Mielants B, Dougados M. Discriminant capacity of clinical and biological variables in ankylosing spondylitis. Rev Rhum (Engl Ed) 1997:64:B92:744.
16. Calin A, Nakache JP, Gueguen A, Zeidler H, Veys E, Dougados M. Discriminant capacity of variables in ankylosing spondylitis between placebo and fast acting drugs [abstract]. Arthritis Rheum 1997;40 Suppl 9:S63.
17. Koh WH, Pande I, Samuels A, Jones SD, Calin A. Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. J Rheumatol 1997;24:2158-61.
18. Dougados M, van der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995;38:618-27.
19. Dougados M, Caporal R, Doury P, et al. A double blind crossover placebo controlled trial of ximoprofen in ankylosing spondylitis [letter]. J Rheumatol 1989; 16:1167-9.
20. Maksymowych WP, Jhangri GS, Leclercq S, Skeith K, Yan A, Russell AS. An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 1998;25:714-7.
21. Dougados M, Nguyen M, Caporal R, et al. Ximoprofen in ankylosing spondylitis. Scand J Rheumatol 1994;23:243-8.
22. Dougados M, Velicitat P, Veys E, Zeidler H, Calin A. Meloxicam in ankylosing spondylitis: a 6 week double-blind comparison with placebo and piroxicam. Rev Rhum (Engl Ed) 1997;64:B91:743.
23. Hidding A, van der Linden S, Boers M, et al. Is group physical therapy superior to individualized therapy in ankylosing spondylitis. Arthritis Care Res 1993;6:117-25.
24. Hidding A, van der Linden S. Factors related to change in global health after group physical therapy in ankylosing spondylitis. Clin Rheumatol 1995;14:347-51.
25. Hidding A, van der Linden S, de Witte L. Therapeutic effects of individual physical therapy in ankylosing spondylitis related to duration of disease. Clin Rheumatol 1993; 12:334-40.
26. Hidding A, van der Linden S, Gielen X, de Witte L, Dijkmans B, Moolenburgh D. Continuation of group physical therapy is necessary in ankylosing spondylitis. Arthritis Care Res 1994;7:90-6.
27. Band DA, Jones SD, Kennedy LG, et al. Which patients with ankylosing spondylitis derive most benefit from an inpatient management program? J Rheumatol 1997:24:2381-1.
28. Calin A, Jones SD, Garrett SL, Kennedy LG. Bath Ankylosing Spondylitis Functional Index [letter]. Br J Rheumatol 1995;34:793-4.
29. Calin A. Can we define the outcome of ankylosing spondylitis and the effect of physiotherapy management? [editorial]. J Rheumatol 1994:21:184-5.
30. Kennedy LG, Edmunds L, Calin A. The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol 1993:20:688-92.
31. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 1996:25:138-42.
32. Kuzis S, Ward MM. Measurement of functional disability in ankylosing spondylitis: a comparison of four self-report questionnaires [abstract]. Arthritis Rheum 1994;37 Suppl 9:S226.
33. Jones SD, Koh WH, Steiner A, Garrett SL, Calin A. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 1996:23:487-90.
34. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score [abstract]. Br J Rheumatol 1995;34 Suppl 1:114.
35. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score. Br J Rheumatol 1996:35:66-71.
36. Stucki G, Daltroy L, Katz JN, Johannesson S, Liang MH. Interpretation of change scores in ordinal scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 1996;49:711-7.
37. Sangha O, Büchi S, Klaghofer R, Rau R, Stucki G. Development of a new short instrument to assess functional status in rheumatoid arthritis patients [abstract]. Arthritis Rheum 1997;40 Suppl:S111.
38. Stucki G, Stucki S, Brühlmann P, Michel BAM. Ceiling effects of the Health Assessment Questionnaire and its modified version in some ambulatory rheumatoid arthritis patients. Ann Rheum Dis 1995:54:461-5.